Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis

Inhibitors of EGF receptor (EGFR) have antifibrotic effects in several organs, but the effect of these inhibitors on the development of peritoneal fibrosis is unknown. Here, we explored the therapeutic effect of gefitinib, a specific inhibitor of EGFR, on the development and progression of peritonea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Soc Nephrol
Autors principals: Wang, Li, Liu, Na, Xiong, Chongxiang, Xu, Liuqing, Shi, Yingfeng, Qiu, Andong, Zang, Xiujuan, Mao, Haiping, Zhuang, Shougang
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2016
Matèries:
Basic Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004637/
https://ncbi.nlm.nih.gov/pubmed/26677863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015030299
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars